CLINICAL IMMUNOLOGY, vol.263, 2024 (SCI-Expanded)
Objective: To derive childhood -onset SLE (cSLE) specific remission definitions for future treat -to -target (T2T) trials, observational studies, and clinical practice. Methods: The cSLE International T2T Task Force conducted Delphi surveys exploring paediatric perspectives on adult -onset SLE remission targets. A modified nominal group technique was used to discuss, refine, and agree on the cSLE remission target criteria. Results: The Task Force proposed two definitions of remission: 'cSLE clinical remission on steroids (cCR) ' and 'cSLE clinical remission off steroids (cCR-0) '. The common criteria are: (1) Clinical-SLEDAI-2 K = 0; (2) PGA score < 0.5 (0 -3 scale); (4) stable antimalarials, immunosuppressive, and biologic therapy (changes due to sideeffects, adherence, weight, or when building up to target dose allowed). Criterion (3) in cCR is the prednisolone dose <= 0.1 mg/kg/day (maximum 5 mg/day), whereas in cCR-0 it is zero. Conclusions: cSLE definitions of remission have been proposed, maintaining sufficient alignment with the adultSLE definition to facilitate life -course research.